Navigation Links
Hypertension Diagnostics Announces Fiscal Year 2007 Results
Date:9/27/2007

ST. PAUL, Minn., Sept. 27 /PRNewswire-FirstCall/ -- Hypertension Diagnostics, Inc. (OTC Bulletin Board: HDII), today announced audited financial results for the fiscal year ended June 30, 2007.

Revenue for fiscal year 2007 totaled $1,878,840 compared to $1,789,546 in the prior year ended June 30, 2006, which represents a 5% increase. The Company incurred a net loss of $504,011 for fiscal year 2007, or $(.01) per share, compared with a net loss of $1,272,742 for fiscal year 2006, or $(.04) per share. Included in the net loss for fiscal year 2007 are total non-cash charges (expenses associated mainly with stock compensation, depreciation, stock options) of $290,989. The Company reported a cash balance on June 30, 2007 of $1,376,632.

Fourth quarter revenue of $438,481, for fiscal year 2007 compared to $295,536 for fiscal year 2006, represented a 48% increase. Revenue for the fourth quarter of fiscal year 2007 decreased by 6.5% compared with $469,151 for the third quarter of fiscal year 2007.

Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company's 2006 Annual Report on Form 10-KSB, and subsequent Quarterly Reports on Form 10-QSB, all of which were filed with the U.S. Securities and Exchange Commission, as well as others not now anticipated.

Hypertension Diagnostics, Inc.

Summary Financial Data

Statements of Operations

Three Months Ended Twelve Months Ended

June 30 June 30

2007 2006 2007 2006

Revenue:

Equipment sales $ 379,100 $ 209,500 $ 1,593,706 $ 1,352,486

Equipment rental 56,707 84,769 255,247 418,979

Service/contract

income 2,674 1,267 29,887 18,081

438,481 295,536 1,878,840 1,789,546

Cost of Sales 18,939 1,483 66,413 90,447

Gross Profit 419,542 294,053 1,812,427 1,699,099

Expenses:

Selling, general

and administrative 447,678 685,958 2,381,310 3,018,624

Total Expenses 447,678 685,958 2,381,310 3,018,624

Operating Loss (28,136) (391,905) (568,883) (1,319,525)

Other Income:

Interest income 14,558 16,338 56,773 46,783

Gain on sale of

property and

equipment - - 8,099 -

Total Other

Income 14,558 16,338 64,872 46,783

Net Loss $ (13,578) $ (375,567) $ (504,011) $(1,272,742)

Basic and Diluted

Net Loss

per Share $ (.00) $ (.01) $ (.01) $ (.04)

Weighted Average

Shares

Outstanding 39,620,262 39,714,469 39,793,320 35,219,474

Balance Sheet Data

June 30, 2007 June 30, 2006

Cash and cash

equivalents $ 1,376,632 $ 1,722,913

Total current assets 1,976,825 2,257,390

Total assets 2,020,385 2,345,949

Total current liabilities 582,124 489,081

Accumulated deficit (26,482,330) (25,978,319)

Total shareholders' equity 1,426,143 1,840,414

CVProfilor is a registered trademark of Hypertension Diagnostics, Inc.

Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved.

Website: http://www.hdii.com


'/>"/>
SOURCE Hypertension Diagnostics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PRIMARY PULMONARY HYPERTENSION GENE DISCOVERED
2. New viewpoint on Hypertension
3. Hypertension drugs could lower Disability
4. Preventing white coat hypertension
5. New drug for hypertension
6. FDA Approves Remodulin for Pulmonary Hypertension
7. Risk of dementia reduced hypertension drugs
8. Glaucoma & Ocular Hypertension more likely in patients with refractive errors
9. Hypertension lowered by Bedtime Dosing
10. An hour of exercise a week cuts hypertension
11. Better Treatment For Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... has partnered with Mediaplanet to help educate the many who are unaware of ... section dedicated to aphasia will run within the “Stroke Awareness” campaign. , The ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... students studying complementary medicine. Allison Outerbridge is this year’s Life University ... May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge is approaching ...
(Date:5/26/2016)... ... ... W.S. Badger Co. Inc ., the maker of certified organic and ... Award for its use of effective workplace strategies to increase business and employee success. ... the Families and Work Institute (FWI) and the Society for Human Resource Management (SHRM), ...
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... ... There are nearly 14.5 million people living with and beyond cancer in ... 5, 2016, communities around the world will gather to recognize these cancer survivors as ... Day® is an annual worldwide Celebration of Life that is held on the first ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016  Zymo Research ... for their new reference materials that help researchers ... sample collection to analyses. The rapid growth of ... for researchers to have standard methods to improve ... generated. Biases inherently exist at every step of ...
(Date:5/25/2016)... , May 25, 2016  Granger Diagnostics today announced ... for wounds and infections. This test ensures discovery ... select viruses. The test requires only a simple swab ... David G. Bostwick , MD, Chief ... facilitate wound healing: "We are excited to make ...
(Date:5/25/2016)... , May 25, 2016 ... 2016"market research report that provides an overview on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
Breaking Medicine Technology: